Kishanda Vyboh

Montreal, QC H3A2B4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Imatinib for highly chemoresistant Kaposi sarcoma in a patient with long-term HIV control: a case report and literature review.

Imatinib for highly chemoresistant Kaposi sarcoma in a patient with long-term HIV control: a case report and literature review.

Journal: Current oncology (Toronto, Ont.)

Published: December 03, 2015

Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.

Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.

Journal: The Journal of antimicrobial chemotherapy

Published: November 11, 2015

Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction.

Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction.

Journal: AIDS reviews

Published: October 10, 2015

Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients.

Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: October 06, 2015

HIV-1 Recruits UPF1 but Excludes UPF2 to Promote Nucleocytoplasmic Export of the Genomic RNA.

HIV-1 Recruits UPF1 but Excludes UPF2 to Promote Nucleocytoplasmic Export of the Genomic RNA.

Journal: Biomolecules

Published: July 07, 2015

Clinical Relevance of Kynurenine Pathway in HIV/AIDS: An Immune Checkpoint at the Crossroads of Metabolism and Inflammation.

Clinical Relevance of Kynurenine Pathway in HIV/AIDS: An Immune Checkpoint at the Crossroads of Metabolism and Inflammation.

Journal: AIDS reviews

Published: June 03, 2015

CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.

CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.

Journal: Journal of the International AIDS Society

Published: February 03, 2015

Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy.

Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy.

Journal: The open AIDS journal

Published: October 27, 2014

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

Journal: The Journal of infectious diseases

Published: October 20, 2014

HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.

HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.

Journal: Journal of immunology research

Published: July 18, 2014

Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.

Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.

Journal: Clinical and experimental immunology

Published: June 05, 2014

eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection.

eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection.

Journal: Nature communications

Published: February 18, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026